BioLineRx (BLRX) Cash from Operations (QoQ) (2013 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | BioLineRx | 9.32 Bn | 9.30 Bn | 154,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -51.95% |
| Sep 30, 2025 | -1,089.83% |
| Jun 30, 2025 | 93.17% |
| Mar 31, 2025 | 69.91% |
| Dec 31, 2024 | 12.37% |
| Sep 30, 2024 | 13.28% |
| Jun 30, 2024 | 19.70% |
| Mar 31, 2024 | -382.69% |
| Dec 31, 2023 | 150.41% |
| Sep 30, 2023 | -2.26% |
| Jun 30, 2023 | -20.78% |
| Mar 31, 2023 | -41.05% |
| Dec 31, 2022 | 34.54% |
| Sep 30, 2022 | -38.05% |
| Jun 30, 2022 | -12.59% |
| Mar 31, 2022 | -1.51% |
| Dec 31, 2021 | -9.77% |
| Sep 30, 2021 | 26.58% |
| Jun 30, 2021 | -9.62% |
| Mar 31, 2021 | -14.67% |
| Dec 31, 2020 | 0.71% |
| Sep 30, 2020 | 1.69% |
| Jun 30, 2020 | 17.41% |
| Mar 31, 2020 | -24.09% |
| Dec 31, 2019 | 11.98% |
| Sep 30, 2019 | 4.28% |
| Jun 30, 2019 | -39.44% |
| Mar 31, 2019 | 10.10% |
| Dec 31, 2018 | 14.47% |
| Sep 30, 2018 | 3.56% |
| Jun 30, 2018 | 8.43% |
| Mar 31, 2018 | -7.64% |
| Dec 31, 2017 | -1.72% |
| Sep 30, 2017 | -47.57% |
| Jun 30, 2017 | -11.07% |
| Mar 31, 2017 | 7.15% |
| Dec 31, 2016 | -36.99% |
| Sep 30, 2016 | 8.58% |
| Jun 30, 2016 | 22.04% |
| Mar 31, 2016 | -31.24% |
| Dec 31, 2015 | 16.87% |
| Sep 30, 2015 | -4.30% |
| Jun 30, 2015 | -6.03% |
| Mar 31, 2015 | 27.34% |
| Dec 31, 2014 | -47.13% |
| Sep 30, 2014 | 25.29% |
| Jun 30, 2014 | -28.04% |
| Mar 31, 2014 | 8.77% |
| Dec 31, 2013 | 14.08% |
| Sep 30, 2013 | 30.47% |
| Jun 30, 2013 | -18.29% |